The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease

Immunobiology

Volumn 215, Issue 4, 2010, Pages 251-263

  Richards, Luke ^a   Ferreira, Daniela M ^b   Miyaji, Eliane N ^b   Andrew, Peter W ^a   Kadioglu, Aras ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Antibody; Nasopharyngeal carriage; Pneumonia; PspA

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 17; OUTER SURFACE PROTEIN A; PNEUMOLYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; EXPERIMENTAL MOUSE; FEMALE; HUMORAL IMMUNITY; MOUSE; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-17; LUNG; MICE; MUTATION; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; VIRULENCE;

EID: 77649186470     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.12.004     Document Type: Article

References (37)

1. Berry A.M., Yother J., Briles D.E., Hansman D., and Paton J.C. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57 (1989) 2037-2042
2. Bogaert D., De Groot R., and Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4 (2004) 144-154
3. Briles D.E., Ades E., Paton J.C., Sampson J.S., Carlone G.M., Huebner R.C., Virolainen A., Swiatlo E., and Hollingshead S.K. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68 (2000) 796-800
4. Darrieux M., Miyaji E.N., Ferreira D.M., Lopes L.M., Lopes A.P., Ren B., Briles D.E., Hollingshead S.K., and Leite L.C. Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition. Infect. Immun. 75 (2007) 5930-5938
5. Douglas R.M., Paton J.C., Duncan S.J., and Hansman D.J. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148 (1983) 131-137
6. Eskola J. Immunogenicity of pneumococcal conjugate vaccines. Pediatr. Infect. Dis. J. 19 (2000) 388-393
7. Ferreira D.M., Darrieux M., Silva D.A., Leite L.C., Ferreira Jr. J.M., Ho P.L., Miyaji E.N., and Oliveira M.L. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16 (2009) 636-645
8. Goldblatt D., Hussain M., Andrews N., Ashton L., Virta C., Melegaro A., Pebody R., George R., Soininen A., Edmunds J., et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192 (2005) 387-393
9. Hansman D., Morris S., Gregory M., and McDonald B. Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory. J. Hyg. (Lond) 95 (1985) 677-684
10. Hill P.C., Cheung Y.B., Akisanya A., Sankareh K., Lahai G., Greenwood B.M., and Adegbola R.A. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin. Infect. Dis. 46 (2008) 807-814
11. Kadioglu A., and Andrew P.W. Susceptibility and resistance to pneumococcal disease in mice. Brief Funct. Genomic Proteomic 4 (2005) 241-247
12. Kadioglu A., Gingles N.A., Grattan K., Kerr A., Mitchell T.J., and Andrew P.W. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68 (2000) 492-501
13. Kadioglu A., Taylor S., Iannelli F., Pozzi G., Mitchell T.J., and Andrew P.W. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70 (2002) 2886-2890
14. Kadioglu A., Coward W., Colston M.J., Hewitt C.R., and Andrew P.W. CD4-T lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72 (2004) 2689-2697
15. Kadioglu A., Weiser J.N., Paton J.C., and Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6 (2008) 288-301
16. Lawrence C.P., Kadioglu A., Yang A.L., Coward W.R., and Chow S.C. The cathepsin B inhibitor, z-FA-FMK, inhibits human T cell proliferation in vitro and modulates host response to pneumococcal infection in vivo. J. Immunol. 177 (2006) 3827-3836
17. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., Harrison L.H., Schaffner W., Reingold A., Bennett N.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051
18. Lu Y.J., Gross J., Bogaert D., Finn A., Bagrade L., Zhang Q., Kolls J.K., Srivastava A., Lundgren A., Forte S., et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4 (2008) e1000159
19. Malley R., Trzcinski K., Srivastava A., Thompson C.M., Anderson P.W., and Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA 102 (2005) 4848-4853
20. McCool T.L., Cate T.R., Moy G., and Weiser J.N. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195 (2002) 359-365
21. McCool T.L., and Weiser J.N. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72 (2004) 5807-5813
22. Mulholland K. Strategies for the control of pneumococcal diseases. Vaccine 17 Suppl. 1 (1999) S79-S84
23. Miyaji E.N., Ferreira D.M., Lopes A.P., Brandileone M.C., Dias W.O., and Leite L.C. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect. Immun. 70 (2002) 5086-5090
24. Ogunniyi A.D., LeMessurier K.S., Graham R.M., Watt J.M., Briles D.E., Stroeher U.H., and Paton J.C. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect. Immun. 75 (2007) 1843-1851
25. Ren B., Szalai A.J., Hollingshead S.K., and Briles D.E. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect. Immun. 72 (2004) 114-122
26. Roche A.M., King S.J., and Weiser J.N. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75 (2007) 2469-2475
27. Hollingshead S.K., Becker R., and Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68 (2000) 5889-5900
28. Shaper M., Hollingshead S.K., Benjamin Jr. W.H., and Briles D.E. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]. Infect. Immun. 72 (2004) 5031-5040
29. Simell B., Kilpi T.M., and Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J. Infect. Dis. 186 (2002) 1106-1114
30. Swiatlo E., King J., Nabors G.S., Mathews B., and Briles D.E. Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis. Infect. Immun. 71 (2003) 7149-7153
31. Syrjanen R.K., Kilpi T.M., Kaijalainen T.H., Herva E.E., and Takala A.K. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J. Infect. Dis. 184 (2001) 451-459
32. Trappetti C., Kadioglu A., Carter M., Hayre J., Iannelli F., Pozzi G., Andrew P.W., and Oggioni M.R. Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J. Infect. Dis. 199 (2009) 1497-1505
33. Trzcinski K., Thompson C., Malley R., and Lipsitch M. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect. Immun. 73 (2005) 7043-7046
34. van Rossum A.M., Lysenko E.S., and Weiser J.N. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect. Immun. 73 (2005) 7718-7726
35. Wernette C.M., Frasch C.E., Madore D., Carlone G., Goldblatt D., Plikaytis B., Benjamin W., Quataert S.A., Hildreth S., Sikkema D.J., et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10 (2003) 514-519
36. Yamamoto M., McDaniel L.S., Kawabata K., Briles D.E., Jackson R.J., McGhee J.R., and Kiyono H. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect. Immun. 65 (1997) 640-644
37. Zhang, Z., Clarke, T.B., and Weiser, J.N. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest.